Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CCK-B Receptor Antagonist 2 is a potent and orally active antagonist of Gastrin/CCK-B (IC50: 0.43 nM). It also inhibits gastrin/CCK-A activity (IC50: 1.82 μM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | 6-8 weeks | $ 446.00 | |
25 mg | 6-8 weeks | $ 1,430.00 | |
50 mg | 6-8 weeks | $ 1,860.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | CCK-B Receptor Antagonist 2 is a potent and orally active antagonist of Gastrin/CCK-B (IC50: 0.43 nM). It also inhibits gastrin/CCK-A activity (IC50: 1.82 μM). |
Targets&IC50 | Gastrin/CCK-A:1.82 μM , Gastrin/CCK-B:0.43 nM |
In vivo | CCK-B Receptor Antagonist 2 (0.1 μmol/kg; i.v.) has an inhibition effect on pentagastrin-induced gastric acid secretion in anesthetized rats (ED50: 8.3 nmol/kg). |
Molecular Weight | 484.55 |
Formula | C27H28N6O3 |
CAS No. | 155412-88-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 250 mg/mL (515.94 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CCK-B Receptor Antagonist 2 155412-88-7 Others CCK B Receptor Antagonist 2 CCKB Receptor Antagonist 2 inhibitor inhibit